NCT00739440

Randomized Controlled Trial to Compare Two Anti-scorpion Serums

Randomized Controlled Trial to Evaluate Efficiency and Safety of the Polyvalent Antiscorpion Serum of Birmex Versus Other Commercial Serum

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 120 (actual)
• Sponsor: Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. · Academic / Other
• Sex: All
• Age: 15 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the efficiency and safety of the treatment against sting scorpion, using two serums, one elaborated by Birmex versus other commercial serum

Detailed description

We consider relevant conduct this study because the poisoning scorpion bite represents a public health problem. This is a randomized clinical trial, which included 120 subjects of both sexes aged 15 and 60 years old and residents of the state of Guanajuato, divided into 2 groups: 60 patients received antiscorpion serum of Birmex and 60 patients receive other commercial serum.

Conditions

• Scorpion Sting

Interventions

Type	Name	Description
BIOLOGICAL	serum antiscorpion	The dose may be required for the patient according to clinical manifestations and evolution

Timeline

• Start date: 2008-08-01
• Primary completion: 2008-10-01
• Completion: 2008-11-01
• First posted: 2008-08-21
• Last updated: 2013-08-07